Biogaia

Biogaia EBITDA per Employee

The EBITDA per Employee of Biogaia (BIOG B.ST) as of Nov 11, 2026 is 2.61 M SEK. In the previous year, EBITDA per Employee was 2.72 M SEK — a change of -4.12% (lower).

EBITDA per Employee

2.61 MSEK

YoY

-4.12%

Last updated:

EBITDA per Employee of Biogaia is 2025 2.61 M SEK. EBITDA per Employee of Biogaia was 2024 2.72 M SEK. It decreases by -4.12% lower compared to the previous year.

The Biogaia EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
1.77 M SEK
Jan 1, 2019
1.56 M SEK
Jan 1, 2020
1.46 M SEK
Jan 1, 2021
1.63 M SEK
Jan 1, 2022
2.32 M SEK
Jan 1, 2023
2.84 M SEK
Jan 1, 2024
2.72 M SEK
Jan 1, 2025
2.61 M SEK
The Biogaia EBITDA per Employee history
YEAREBITDA per EmployeeYoY
2.61 MSEK-4.12%
2.72 MSEK-4.26%
2.84 MSEK+22.55%
2.32 MSEK+42.05%
1.63 MSEK+11.52%
1.46 MSEK-6.02%
1.56 MSEK-11.83%
1.77 MSEK+18.55%
1.49 MSEK+17.00%
1.27 MSEK+30.34%
977,797.47SEK-21.53%
1.25 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

EBITDA per Employee of Biogaia is 2.61 M SEK in 2025.

EBITDA per Employee of Biogaia changed from 2.72 M SEK to 2.61 M SEK, representing a -4.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Biogaia since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Biogaia historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Biogaia

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Biogaia